Anna Szymanowska

971 total citations
16 papers, 342 citations indexed

About

Anna Szymanowska is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Anna Szymanowska has authored 16 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Anna Szymanowska's work include Synthesis and biological activity (8 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Quinazolinone synthesis and applications (5 papers). Anna Szymanowska is often cited by papers focused on Synthesis and biological activity (8 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Quinazolinone synthesis and applications (5 papers). Anna Szymanowska collaborates with scholars based in Poland, United States and Spain. Anna Szymanowska's co-authors include Krzysztof Bielawski, Anna Bielawska, Agnieszka Gornowicz, Mariusz Mojzych, Robert Czarnomysy, Paola Amero, Mateusz Kciuk, Teslime Özge Şahin, Raffaele Capasso and Donatella Cicia and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Phytotherapy Research.

In The Last Decade

Anna Szymanowska

16 papers receiving 296 citations

Peers

Anna Szymanowska
Anna Szymanowska
Citations per year, relative to Anna Szymanowska Anna Szymanowska (= 1×) peers Mona H. Ibrahim

Countries citing papers authored by Anna Szymanowska

Since Specialization
Citations

This map shows the geographic impact of Anna Szymanowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Szymanowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Szymanowska more than expected).

Fields of papers citing papers by Anna Szymanowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Szymanowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Szymanowska. The network helps show where Anna Szymanowska may publish in the future.

Co-authorship network of co-authors of Anna Szymanowska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Szymanowska. A scholar is included among the top collaborators of Anna Szymanowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Szymanowska. Anna Szymanowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Radomska, Dominika, Robert Czarnomysy, Anna Szymanowska, et al.. (2024). Di- and Triselenoesters—Promising Drug Candidates for the Future Therapy of Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 25(14). 7764–7764. 2 indexed citations
2.
Radomska, Dominika, Olga Klaudia Szewczyk-Roszczenko, Krzysztof Marciniec, et al.. (2024). Evaluation of anticancer activity of novel platinum(II) bis(thiosemicarbazone) complex against breast cancer. Bioorganic Chemistry. 148. 107486–107486. 2 indexed citations
3.
Lara, Olivia D., Anna Szymanowska, Emine Bayraktar, et al.. (2024). Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside. Cancers. 16(17). 2940–2940. 11 indexed citations
4.
Szymanowska, Anna, Dominika Radomska, Robert Czarnomysy, et al.. (2024). The activity of pyrazolo[4,3- e ][1,2,4]triazine and pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2343352–2343352. 4 indexed citations
5.
Szymanowska, Anna, Cristian Rodriguez‐Aguayo, Gabriel Lopez‐Berestein, & Paola Amero. (2023). Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment. Non-Coding RNA. 9(5). 52–52. 8 indexed citations
6.
Şahin, Teslime Özge, Birsen Yılmaz, Donatella Cicia, et al.. (2023). Recent insights into the nutritional immunomodulation of cancer‐related microRNAs. Phytotherapy Research. 37(10). 4375–4397. 62 indexed citations
7.
Kciuk, Mateusz, Somdutt Mujwar, Anna Szymanowska, et al.. (2022). Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies. International Journal of Molecular Sciences. 23(11). 5892–5892. 26 indexed citations
8.
Radomska, Dominika, Robert Czarnomysy, Anna Szymanowska, et al.. (2022). Novel Selenoesters as a Potential Tool in Triple-Negative Breast Cancer Treatment. Cancers. 14(17). 4304–4304. 14 indexed citations
9.
Bielawska, Anna, Anna Szymanowska, Agnieszka Gornowicz, et al.. (2022). New 1,3,4-Thiadiazole Derivatives with Anticancer Activity. Molecules. 27(6). 1814–1814. 39 indexed citations
10.
Gornowicz, Agnieszka, Anna Szymanowska, Mariusz Mojzych, et al.. (2021). The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells. Molecules. 26(7). 2045–2045. 26 indexed citations
11.
Szymanowska, Anna, Agnieszka Gornowicz, Anna Bielawska, & Krzysztof Bielawski. (2021). [1,2,4]triazyny – potencjalne leki w chemioterapii nowotworów. Postępy Higieny i Medycyny Doświadczalnej. 75(1). 64–84. 23 indexed citations
12.
Hermanowicz, Justyna Magdalena, Anna Szymanowska, Robert Czarnomysy, et al.. (2021). Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 535–548. 28 indexed citations
13.
Szymanowska, Anna, et al.. (2020). Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-e][1,2,4]triazine Derivatives. Molecules. 25(17). 3948–3948. 31 indexed citations
14.
Gornowicz, Agnieszka, Anna Szymanowska, Mariusz Mojzych, Krzysztof Bielawski, & Anna Bielawska. (2020). The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells. International Journal of Molecular Sciences. 21(15). 5221–5221. 44 indexed citations
15.
Gornowicz, Agnieszka, Anna Bielawska, Anna Szymanowska, et al.. (2019). Monoclonal anti‑MUC1 antibody with novel octahydropyrazino[2,1‑a:5,4‑a']diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast cancer cells. Oncology Reports. 42(4). 1391–1403. 8 indexed citations
16.
Gornowicz, Agnieszka, Anna Bielawska, Arkadiusz Surażyński, et al.. (2018). The molecular mechanism of anticancer action of novel octahydropyrazino[2,1-a:5,4-a′]diisoquinoline derivatives in human gastric cancer cells. Investigational New Drugs. 36(6). 970–984. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026